Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK EVER: Everolimus vs IS Reduction Alone for BK Viremia in Kidney Transplant
NCT03216967Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jan 2018
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in BK virus infection, sponsored by Strasbourg University Hospital. Started Jan 2018; status: completed.
02
Drugs
everolimus
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT03216967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216967.